5 mm slice gap); fluid attenuated inversion recovery (FLAIR) (TR/

5 mm slice gap); fluid attenuated inversion recovery (FLAIR) (TR/TE=9002/147

ms, 256×256 matrix, 240×240 mm FOV, 5 mm slice thickness, 1.5 mm slice gap); and gradient echo (T2⁎-weighted) (TR/TE=620/15 ms, flip angle α=20°, 240×180 mm FOV, 256×192 matrix, 5 mm slice thickness, 1 mm slice gap)]. DCE-MRI was performed using a 3D selleck chemicals fast spoiled gradient echo (FSPGR) sequence (TR/TE=8.1/3.2 ms, 240×240 mm FOV, 256×256 matrix, 4 mm slice thickness). The sequence was run before contrast agent administration with flip angles of 2° and 12° to facilitate T10 measurement [21], [22], [23], [24], [25] and [26], and the 12° acquisition was repeated 26 times with a temporal resolution of 69 s following an intravenous bolus injection of 40 ml gadodiamide (Omniscan, GE Healthcare, Chalfont St Giles, UK) into the antecubital vein. In order to assess scanner drift, the DCE-MRI protocol was also performed on six healthy volunteers without administration of contrast agent and on gadodiamide-doped water phantoms with T10 values representative of brain tissue and cerebrospinal fluid (CSF). An

experienced neuroradiologist examined the T2-weighted and FLAIR sequences from all patients in detail, classifying deep and periventricular white matter abnormalities according DAPT mw to the Fazekas scale (range 0 to 3) [27]. The scores for deep and periventricular abnormalities were averaged to give an overall Fazekas white matter rating and patients were dichotomized into those with overall Fazekas rating <1.5 (low) or ≥1.5 (high). The DCE-MRI data were motion corrected

by aligning all FSPGR acquisitions to the pre-contrast 12° acquisition using computational image realignment [28]. Maps of T10 were calculated voxel by voxel from the two pre-contrast acquisitions, Sa and Sb, acquired with flip angles αa=2° and αb=12° using the formula adapted from Brookes et al. [22] equation(1) 1T10=1TRln[SRsinαbcosαa−sinαacosαbSRsinαb−sinαa]where SR=Sa/Sb. Signal enhancement (Et) maps were calculated voxel by voxel for each of the 26 post-contrast time points t, such that Et=(St−S0)/S0, where S0 is the pre-contrast 12° acquisition. Fluorouracil solubility dmso The signal enhancement represents the fractional signal increase above baseline, such that a value of 0 represents no post-contrast signal increase and a value of 1 represents a doubling of post-contrast signal. Maps of contrast agent concentration Ct (in millimolars) were estimated from Et at each time point by voxel-by-voxel numerical solution of the formula given in Eq. ( 2) [29], equation(2) Et=exp(−r2CtTE)×[1−exp(−P−Q)−cosα2(exp(−P)−exp(−2P−Q))1−exp(−P)−cosα2(exp(−P−Q)−exp(−2P−Q))]−1where P=TR/T10 and Q=r1CtTR. This method makes the standard assumption that the post-contrast changes in R1 and R2⁎ are linearly related to Ct as determined by the contrast agent relaxivities r1 and r2.

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>